Trials / Completed
CompletedNCT02530281
Study of Glycopyrronium in Axillary Hyperhydrosis
A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of Glycopyrronium in Subjects With Axillary Hyperhydrosis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 344 (actual)
- Sponsor
- Journey Medical Corporation · Industry
- Sex
- All
- Age
- 9 Years
- Healthy volunteers
- Not accepted
Summary
The study is a randomized, double-blind, vehicle controlled, parallel group study, designed to assess the efficacy and safety of glycopyrronium topical wipes, once daily, compared to vehicle in subjects with axillary hyperhidrosis.
Detailed description
This is a randomized, double-blind vehicle controlled study to assess the efficacy and safety of glycopyrronium topical wipes compared to vehicle in subjects with axillary hyperhidrosis. Safety will be assessed through lab tests, ECG, physical exams and vital signs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | glycopyrronium Topical Wipes | Topical wipes containing glycopyrronium |
| OTHER | Vehicle | Vehicle (placebo) topical wipes |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-08-21
- Last updated
- 2021-08-25
- Results posted
- 2018-08-14
Locations
31 sites across 2 countries: United States, Germany
Source: ClinicalTrials.gov record NCT02530281. Inclusion in this directory is not an endorsement.